Optimized strategy for percutaneous coronary interventio
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0009522
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 1936
?Subject must be = 19 years.
?Subject is able to verbally confirm understandings of risks, benefits and treatment alternatives of receiving invasive physiologic or imaging evaluation and PCI with a drug-eluting stent (DES) and he/she or his/her legally authorized representative provides written informed consent.
?Subjects suspected with ischemic heart disease.
?Subjects with coronary artery diameter stenosis 50-90% by angiography-based visual estimation eligible for stent implantation.
?Target vessel size = 2.5mm in visual estimation.
?Known hypersensitivity or contraindication to any of the following medications: Heparin, Aspirin, Clopidogrel, Prasugrel, Ticagrelor.
?Active pathologic bleeding.
?Gastrointestinal or genitourinary major bleeding within the prior 3 months.
?History of bleeding diathesis, known coagulopathy.
?Non-cardiac co-morbid conditions with life expectancy < 2 year.
?Target lesion located in coronary arterial bypass graft.
?Left main coronary artery diameter stenosis = 50%.
?Chronic total occlusion in the study target vessel.
?Culprit lesion of STEMI
?Not eligible for angiography-derived FFR (ostial RCA = 50% stenosis, severe tortuosity, severe overlap, poor image quality)
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method